Call for Abstract

5th International conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics , will be organized around the theme “Emphasizing the Knowledge of Personalized Medicine”

Euro Personalized Medicine 2016 is comprised of 23 tracks and 122 sessions designed to offer comprehensive sessions that address current issues in Euro Personalized Medicine 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

In personalized medicine molecular diagnostics is used for analysing of biological markers and also analysing by applying molecular biology to medical testing .This technique is used to diagnose and monitor disease,detect risk in individual patients .DNA sequencing is the process of determining the precise order of nucleotides within a DNA  molecule .SNP genotyping is the measurement of genetic variations of single nucleotide polymorphism (SNPs) . which is the measurement of more general genetic variation.Gene expression  profiling is used for the measurement of  the activity of thousands of genes at once.

  • Track 1-1Personalized medicine for osteoporosis
  • Track 1-2Molecular diagnostics in personalized medicine
  • Track 1-3Oncology
  • Track 1-4Molecular pathology
  • Track 1-5DNA sequencing
  • Track 1-6 Biochip and microarrays in personalized medicine
  • Track 1-7SNP genotyping
  • Track 1-8Gene expression profiling
  • Track 1-9Proteomics vs genomics in personalized medicine

In personalized medicine  biomarkers and  biological marker  generally refers to a measurable indicator  of some biological state or condition. This word  refer to a substance the presence of which indicates the existence of a living organism. Biochemical biomarkers are often used in clinical trials, Biomarkers used for personalized medicine are typically categorized as either prognostic or predictive .In  , a biomarkers is a molecule that allows the detection and isolation of a particular cell type .  A biomarker indicates a change in  state of a protein that correlates with the risk or progression of a disease . Biomarkers are useful in a number of ways, including measuring the progress of disease. Biomarkers also used in  early diagnosis, disease prevention, drug target identification, drug response etc.

  • Track 2-1Molecular biomarkers
  • Track 2-2DNA biomarkers
  • Track 2-3Anti HER-2 Therapy
  • Track 2-4Predictive biomarkers
  • Track 2-5Protein microarray personalized medicine
  • Track 2-6Bioinformatics in personalized medicine

In personalized medicine pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which can affect the drug responses, like therapeutic effect as well as adverse effect. Inter- and intra-individual variation in gene expression and  its function.In oncology, pharmacogenetics refers to germline mutations and pharmacogenomics is study the somatic mutations in tumoral DNA leading to alteration in drug response.

  • Track 3-1Molecular diagnostics in pharmacogenetics
  • Track 3-2Polymorphism of drug transporters
  • Track 3-3Cancer chemotherapy
  • Track 3-4Genetic variation in drug targets
  • Track 3-5CYP2C19 pharmacogenetics in personalized medicine
  • Track 3-6Future prospects for pharmacogenetics

Pharmacogenomics is the study of  the role of genetics in drug response. It deals with the influence of acquired and inherited genetic variation on drug response, drug absorption distribution, metabolism, and elimination ,as well as drug receptor target effects . Pharmacogenomics isoften used interchangeably with pharmacogenetics. Pharmacogenomics is used for the detection of   the individual genetic variation with drug responses pharmacogenetics focuses on single drug-gene interactions, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.

 

  • Track 4-1Pharmacogenomics vs pharmacogenetics
  • Track 4-2Genetic profiling on clinical studies
  • Track 4-3Future prospects of pharmacogenomics

The proteome is the entire set of proteins it is expressed by genome , cell, tissue, or organism at a certain time. More specifically, it is a combined of proteins and genomes . Proteomics is the study of the proteome. A cellular  proteome is the collection of proteins present in a particular cell type and it exposure to harmone stimulation . It can also be useful to consider an organisms complete proteome, which can be conceptualized as the complete set of proteins from all of the various cellular proteomes. Proteome used to refer to the collection of proteins in certain sub-cellular biological systems .

  • Track 5-1Pharmacometabonomic in humans
  • Track 5-2DNA and RNA microarrays
  • Track 5-3Nanoproteomics and genomics
  • Track 5-4Pharmacoproteomics in personalized medicine
  • Track 5-5Proteomics in personalized medicine

Metabolomics is defined as the chemical processes involving of  metabolites. Metabolomics is the  study of the unique chemical fingerprints. The metabolome refers to the collection of all metabolites in a biological cell, tissue, organ or organism. mRNA gene expression data and proteomic analyses reveals the set of gene products in the cell. One of the challenges of system biology and functional genomics  is to integrate proteomic ,transcriptomic, and metabolomic information to provide a cellular biology.

  • Track 6-1Metabolomics and metabonomics
  • Track 6-2Oncology in personalized medicine
  • Track 6-3Metabolic phenotyping
  • Track 6-4Bioinformatics for personalized medicine
  • Track 6-5Personalized nutrition

Personalized medicine is a Medical Practice that separates patients into different groups with medical decisions, practices, interventions and  products being tailored to the individual patient based on their predicted response or risk of disease. The words of  personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably.

  • Track 7-1Personalized medicine for diabetes
  • Track 7-2Personalized medicine for GI disorders
  • Track 7-3Personalized geriatrics
  • Track 7-4Personalized medicine for skin disorders
  • Track 7-5Personalized preventive medicine
  • Track 7-6Personalized medicine for osteoporosis
  • Track 7-7Personalized medicine for renal disease

Epigenomics is a set of epigenetic modifications on the genetic material of a cell is called as the epigenome. Epigenetics are reversible modifications on a cells DNA that affect the gene expression without altering the DNA sequence. Epigenetic modifications are important role  in the  gene expression and regulation, that are involved in the  numerous cellular processes such as tumorigenesis.

 

  • Track 8-1Cancer genomics
  • Track 8-2Genotyping and genomic profiling
  • Track 8-3Epigenomics and personalized medicine
  • Track 8-4Cytomics in personalized medicine
  • Track 8-5Nanobiotechnology in personalized medicine
  • Track 8-6Biosensors in Personalized Medicine

Biological therapy refers to the use of medication , specifically target an immune or genetic mediator of disease. Even for diseases of unknown cause of  molecules that are involved in the disease process have been identified, and can be targeted for biological therapy. which are mainly cytokines , are directly involved in the immune system .Biological therapy used for the management of cancer , autoimmune disease, and diseases of unknown cause that result in symptoms due to immune related mechanisms.

  • Track 9-1Recombinant human proteins
  • Track 9-2Personalized therapy in lung cancer
  • Track 9-3Stem cell in personalized gene therapy
  • Track 9-4Nanobiotechnology
  • Track 9-5Treating breast cancer 21st century

Cancer is cured by surgery ,chemotherapy , radiation therapy , hormonal therapy  and targeted therapy including immuno therapy such as monoclonal antibody therapy. The choice of therapy depends upon the location ,tumor and stage of disease as well as the general state of the patient.

  • Track 10-1Molecular imaging in personalized medicine
  • Track 10-2Immunotherapy of cancer
  • Track 10-3Personalized cancer vaccines
  • Track 10-4Personalized radiation therapy
  • Track 10-5Oncoproteomics in personalized medicine

Infection is invasion of an organisms , body tissues by disease causing agents their multiplication and the reaction of  host tissues to these organisms and they produced toxins . Infectious disease also known as transmissible disease and  communicable disease, is illness resulting from an infection.

  • Track 11-1Personalized management in bacterial infections
  • Track 11-2Personalized management TB
  • Track 11-3Personalized management Fungal infections
  • Track 11-4Personalized management Malaria
  • Track 11-5Personalized management Viral infections

A neurological disorder is any disorder r of the body nervous system. Structural, biochemical or electrical abnormalities of brain, spinal cord or other nerves can result in a range of symptoms. The symptoms include paralysis, muscle weakness , loss of sensation,seizures confusion pain and altered levels of consciousness.They may be assessed by neurological examination, studied and treated within the specialities of nuerology and clinical neuropsychology.

  • Track 12-1Personalized medicine in neurological disoders
  • Track 12-2Neurogenomics
  • Track 12-3Neuroproteomics
  • Track 12-4Neurometabolomics
  • Track 12-5Personalized medicine in Parkinson disease
  • Track 12-6Personalized management of pain
  • Track 12-7Personalized management of epilepsy
  • Track 12-8Personalized management of migrane
  • Track 12-9Personalized management of traumatic brain injury

Mental disorders are  psychological condition primarily by sufficient disorganization of  personality, mind, emotions to seriously impair the normal psychological condition. Mental disorders occasionally consist a combination of affective behavioural cognitive perceptual components. The acknowledgement of mental health conditions has changed over time and across cultures, and still observed variations in the definition,classification,and treatment of mental disorders.

  • Track 13-1Psychopharmacogenetics/psychopharmacodynamics
  • Track 13-2Personalized antipsychotic therapy
  • Track 13-3Personalized in ADHD
  • Track 13-4Personalized therapy for smoking cessation
  • Track 13-5 Prospects in personalized psychiatry

Cardiovascular disorders is require an organized interpretation of variations in DNA and mRNA as well as proteins. The advance biotechnology is being applied to improve the diagnosis and treatment of cardiovascular disorders. A five-step strategy can be followed to identify genes and gene products involved in differential responses to cardiovascular drugs.

  • Track 14-1Diagnostics in personalized management
  • Track 14-2Biomarkers in CV disoders
  • Track 14-3Nanobiotechnology in personaliz cv diseases
  • Track 14-4 Personalized management of hypertension
  • Track 14-5Personalized management of chronic myocardial ischemia
  • Track 14-6Thrombotic disorders
  • Track 14-7Personalized management of interstitial disease

Chronic obstructive pulmonarydisease is a type of  obstructive lung disease characterized. The main symptoms includes a breath and cough  with suptum production.COPD typically worsens over time . Eventually walking up stairs or carrying things will be difficult. Tobacco smoking is the most common with a number of other factors such as air pollution and genetics.

  • Track 15-1Personalized therapy of asthma
  • Track 15-2Therapy of chronic pulmonary disease
  • Track 15-3Personalized management interstitial lung disease
  • Track 15-4Lebrikizumab for personalized treatment of asthma

Genetic disorders may or may not be heritable from the parents genes. In non-heritable genetic disorders, defects may be caused by new mutations  and changes to the DNA. In such cases, the defect will only be heritable if it occurs in the germ line .Such as some forms of cancer, may be caused by an inherited genetic condition in some people by new mutations in other people, and mainly by environmental causes in other people. Whether, when and to what extent a person with the genetic defect abnormality will actually suffer from the disease is almost always affected by the environmental factors and events in the persons development.

  • Track 16-1Molecular diagnostics in genetic disorders
  • Track 16-2Biomarkers in genetic disorders
  • Track 16-3Personalized medicine in Era of genomics
  • Track 16-4By massively parallel DNA sequencing
  • Track 16-5Personalized treatment of cystic fibrosis

Autoimmune diseases is damage a pathologic state arising from an abnormal immune response of the body against substances and tissues are normally present in the body. Autoimmunity is the presence of self-reactive immune response. (e.g., auto-antibodies and  self-reactive T-cells) with or without damage or pathology resulting from it.

  • Track 17-1Molecular neurobiology of depression
  • Track 17-2Immune biomarkers
  • Track 17-3Personalized therapy of rheumatoid arthritis
  • Track 17-4Personalized vaccinology
  • Track 17-5Personalized organ transplantation

Personalized medicine is a Medical Practice that separates patients into different groups with medical decisions, practices, interventions and  products being tailored to the individual patient based on their predicted response or risk of disease. The words of  personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably.

  • Track 18-1Personalized nutrition
  • Track 18-2Nutrigenomics
  • Track 18-3Personalized diet prescription
  • Track 18-4Personalized surgery
  • Track 18-5Personalized physical exercise

The FDA is  already started to take initiatives to integrate personalized medicine into their regulatory policies.They developed a report in October 2013 entitled Paving the Way for Personalized Medicine FDAs role in a New Era of Medical Product Development in which they outlined steps they would have to take to integrate genetic and biomarker information for clinical use and drug development. They determined that they would have to develop specific regulatory science standards, research methods, reference material and other tools in order to incorporate personalized medicine into their current regulatory practices. For example, they are working on a genomic reference library for regulatory agencies to compare and test the validity of different sequencing platforms in an effort to uphold reliability.

  • Track 19-1FDA and Personalized medicine
  • Track 19-2Regulatory aspects of pharmacogenetics
  • Track 19-3FDA and validation of biomarkers
  • Track 19-4FDA and predictive medicine

 Health economics is a study of economics concerned with issues related to efficiency, effectiveness, value , behavior in the consumption of  healthcare. In broad terms health economists study the functioning of healthcare systems and health-affecting behaviors such as smoking.Health economists evaluate multiple types of financial information costs, charges and expenditures.

  • Track 20-1Genetic testing for healthcare
  • Track 20-2Personalized medicine in orphan drug syndrome
  • Track 20-3Economics for Personalized medicine
  • Track 20-4Lowering the high costs of cancer chemotherapy

Medical ethics is a system of moral principles that apply values and judgments to medical practice. As a scholarly discipline, medical ethics encompasse its application in clinical settings as well as work on its history, philosophy, and sociology.

  • Track 21-1Ethical aspects of genetic information
  • Track 21-2Gene patents and Personalized medicine
  • Track 21-3Genotype in clinical trails

Personalized medicine is a Medical Practice that separates patients into different groups with medical decisions, practices, interventions and  products being tailored to the individual patient based on their predicted response or risk of disease. The words of  personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably.

  • Track 22-1Personalized medicine coalition
  • Track 22-2Personalized drug discovery
  • Track 22-3Drug delivery in personalized medicine
  • Track 22-4Health services in personalized medicine
  • Track 22-5Personalized prognosis of disease

Personalized medicine is a Medical Practice that separates patients into different groups with medical decisions, practices, interventions and  products being tailored to the individual patient based on their predicted response or risk of disease. The words of  personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably.

  • Track 23-1Translational science in Personalized medicine
  • Track 23-2Opportunities for Personalized medicine
  • Track 23-3Future of Personalized medicine
  • Track 23-4Testing for healthcare